Insights

Partner Collaboration Athenex's partnership with Quantumleaphealth for the I-SPY 2 TRIAL highlights potential collaboration opportunities with other companies in the biopharmaceutical sector to drive innovation and expand market reach.

Asset Sale The recent sale of assets to Sagent Pharmaceuticals presents an opportunity for Athenex to explore further asset sales or partnerships to optimize its portfolio and focus on core areas of growth and development.

Talent Redistribution Following a decrease in headcount and office closures, there is a chance for Athenex to recruit new talent or engage with service providers to enhance operational efficiency and reinforce key strategic areas.

Market Expansion By leveraging its global presence and unique manufacturing supply chain across China and North America, Athenex can explore new market expansion strategies to capitalize on emerging pharmaceutical markets and diversify revenue streams.

Technology Integration Athenex's tech stack comprising SAS, Oracle, and other advanced tools signals an opportunity to integrate cutting-edge technologies for drug discovery, manufacturing process optimization, and data-driven decision-making to drive sales growth and competitive advantage.

Similar companies to Athenex

Athenex Tech Stack

Athenex uses 8 technology products and services including SAS, Fastly, Hyperion, and more. Explore Athenex's tech stack below.

SAS
Business Intelligence
Fastly
Content Delivery Network
Hyperion
Corporate Performance Management
Oracle
Enterprise
Typekit
Font Scripts
Dayforce HCM
Human Resource Management System
jQuery
Javascript Libraries
Animate.css
UI Frameworks

Media & News

Athenex's Email Address Formats

Athenex uses at least 2 format(s):

Athenex Email Formats	Example	Percentage
FLast@athenex.com	JDoe@athenex.com	77%
FirstLast@athenex.com	JohnDoe@athenex.com	20%
FirLast@athenex.com	JohDoe@athenex.com	2%
Last.First@athenex.com	Doe.John@athenex.com	1%
FLast@kinexpharma.com	JDoe@kinexpharma.com	66%
Last@kinexpharma.com	Doe@kinexpharma.com	31%
Last_First@kinexpharma.com	Doe_John@kinexpharma.com	3%

Frequently Asked Questions

Where is Athenex's headquarters located?

Athenex's main headquarters is located at 1001 Main Street Suite 600 Buffalo, New York 14203 US. The company has employees across 4 continents, including North AmericaSouth AmericaAsia.

What is Athenex's phone number?

You can contact Athenex's main corporate office by phone at

+1-716-898-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Athenex's stock symbol?

Athenex is a publicly traded company; the company's stock symbol is ATNXQ.

What is Athenex's official website and social media links?

Athenex's official website is athenex.com and has social profiles on LinkedIn.

How much revenue does Athenex generate?

As of July 2024, Athenex's annual revenue reached $75M.

What is Athenex's SIC code NAICS code?

Athenex's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Athenex have currently?

As of July 2024, Athenex has approximately 201 employees across 4 continents, including North AmericaSouth AmericaAsia. Key team members include Chief Scientific Officer: D. H.Chief Medical Officer: R. K.Chief Business And Commercial Officer, Athenex: T. C.. Explore Athenex's employee directory with LeadIQ.

What industry does Athenex belong to?

Athenex operates in the Pharmaceutical Manufacturing industry.

What technology does Athenex use?

Athenex's tech stack includes SASFastlyHyperionOracleTypekitDayforce HCMjQueryAnimate.css.

What is Athenex's email format?

Athenex's email format typically follows the pattern of . Find more Athenex email formats with LeadIQ.

How much funding has Athenex raised to date?

As of July 2024, Athenex has raised $30M in funding. The last funding round occurred on Aug 11, 2022 for $30M.

Athenex

Pharmaceutical ManufacturingNew York, United States201-500 Employees

Athenex is a global specialty oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases and supportive therapies.

The company is dedicated to delivering innovative drugs that can have a life-changing impact on cancer patients.  Our business includes medical technology innovation centers and a unique manufacturing supply chain across both China and North America. Through the connected innovation and manufacturing supply chain presence, we can identify, develop and deliver proprietary medical technology across continents and multiple regulatory environments.

Company Overview

Headquarters: 1001 Main Street Suite 600 Buffalo, New York 14203 US
Phone number: ✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-716-898-****
Website: athenex.com
SIC Code: 2834 - Pharmaceutical Preparations
Stock Symbol: ATNXQ
NAICS Code: 3254 - Pharmaceutical and Medicine Manufacturing
Employees: 201-500

Media & News

Funding & Financials

$30M
Athenex has raised a total of $30M of funding over 10 rounds. Their latest funding round was raised on Aug 11, 2022 in the amount of $30M.
$50M$100M
Athenex's revenue is in the range of $50M$100M

Funding & Financials

$30M
Athenex has raised a total of $30M of funding over 10 rounds. Their latest funding round was raised on Aug 11, 2022 in the amount of $30M.
$50M$100M
Athenex's revenue is in the range of $50M$100M

Company Leadership

D. H.
Chief Scientific Officer
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. K.
Chief Medical Officer
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. C.
Chief Business And Commercial Officer, Athenex
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. K.
Vice President Clinical And Regulatory Affairs
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. F.
Executive Assistant & Project Specialist, Offices Of The President And Chief Operating Officer
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

T. C.
Chief Business And Commercial Officer, Athenex
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. K.
Vice President Clinical And Regulatory Affairs
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. M.
Vice-President
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
L. R. R.
National Sales Director
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. C.
Sr. Director, Manufacturing
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Athenex and Millions of Other Companies
Sign up for full access to Athenex information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Athenex

Agios Pharmaceuticals

Blueprint Medicines

Atara Biotherapeutics

Aileron Therapeutics

Mersana Therapeutics

Ikena Oncology

Athenex Tech Stack

Media & News

Athenex sold assets to Sagent Pharmaceuticals on Jun 1st '23.

Athenex closed offices in New York, New York, United States on Aug 10th '23.

Hangauer retired from Athenex as chief scientific officer on Dec 1st '16.

Athenex partners with Quantumleaphealth.

Athenex decreased headcount by 92 on Jan 1st '21.

Athenex closed offices in Newstead, New York, United States on Mar 17th '22.

Srivastava leaves Athenex as Vice President, Cell Therapy Development.

Athenex's Email Address Formats

Frequently Asked Questions

Where is Athenex's headquarters located?

What is Athenex's phone number?

What is Athenex's stock symbol?

What is Athenex's official website and social media links?

How much revenue does Athenex generate?

What is Athenex's SIC code NAICS code?

How many employees does Athenex have currently?

What industry does Athenex belong to?

What technology does Athenex use?

What is Athenex's email format?

How much funding has Athenex raised to date?

Athenex

Company Overview

Media & News

Athenex sold assets to Sagent Pharmaceuticals on Jun 1st '23.

Athenex closed offices in New York, New York, United States on Aug 10th '23.

Hangauer retired from Athenex as chief scientific officer on Dec 1st '16.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?